Trial Profile
Connectivity Affecting the Antidepressant REsponse (The CAARE Study)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Sep 2021
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary) ; Bupropion
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms CAARE
- 20 Aug 2020 Status changed from recruiting to completed.
- 19 Aug 2019 Planned End Date changed from 1 Oct 2019 to 1 Oct 2020.
- 19 Aug 2019 Planned primary completion date changed from 1 Oct 2019 to 1 Oct 2020.